Aduro BioTech to acquire BioNovion Holding - MarketLine Financial Deals

Aduro BioTech to acquire BioNovion Holding

Aduro BioTech to acquire BioNovion Holding - MarketLine Financial Deals
Aduro BioTech to acquire BioNovion Holding
Published Sep 24, 2015
2 pages — Published Sep 24, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Aduro BioTech, Inc., a US-based cancer immunotherapy company, has entered into a definitive agreement to acquire BioNovion Holding B.V.

  
Source:
Document ID
MA159810_150929
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Aduro BioTech to acquire BioNovion Holding" Sep 24, 2015. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aduro-BioTech-to-acquire-BioNovion-Holding-2052-113371>
  
APA:
MarketLine Financial Deals. (2015). Aduro BioTech to acquire BioNovion Holding Sep 24, 2015. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aduro-BioTech-to-acquire-BioNovion-Holding-2052-113371>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.